Ireland and Ulster legend Tommy Bowe has called out Rory McIlroy's stance on LIV Golf, suggesting his other commitments make it hypocritical.

Amgen recently faced a legal setback, with a U.S. District Court jury finding the company liable for antitrust violations and awarding Regeneron Pharmaceuticals $406.8 million in damages.

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...

Adjusted EPS $4.90 vs LSEG estimate of $4.30 Revenue of $8.1 billion in line with Wall Street estimates 2025 outlook reaffirmed May 1 (Reuters) - Amgen (AMGN.O), opens new tab on Thursday said its ...

Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect. Amgen beat analysts’ revenue expectations by 2.6% last quarter, reporting revenues of ...

The WTO expects the world’s overall volume of merchandise trade is expected to take a blow of ... NVIDIA was last seen trading 10.3 per cent lower at $100.7 apiece, while Apple and Amgen were down 5.0 ...

Amgen Inc.'s stock has surged 13% recently, likely due to promising developments with its obesity injection, MariTide, which offers unique benefits over current treatments. MariTide's dual ...

9 Although Amgen disclosed the existence of the transfer pricing dispute ... 10 Customs overlap with transfer pricing Merchandise imported into the United States is appraised for customs purposes in ...

Amgen is a biotechnology leader with competitive advantages in scale, R&D, manufacturing efficiency, and distribution, bolstered by a robust pipeline and rising margins. I currently rate Amgen as ...

Biotechnology specialist Amgen (NASDAQ:AMGN) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. Analysts estimated Q4 adjusted EPS ...

Three years after beginning construction in southwestern Wake County, the pharmaceutical company Amgen celebrated the completion of its $550 million manufacturing plant in the town of Holly ...

Mario Tama / Getty Images A Phase 2 study of Amgen's experimental weight-loss treatment didn't meet expectations of analysts. Concerns were also raised about the drug's side effects and the number ...